Join Dr. Donna Ryan, Professor Emeritus at Pennington Biomedical Research Center at Baton
Rouge in Louisiana, alongside leading experts in the field of obesity and weight management, as they dive into challenges and strategies for the treatment of obesity in this podcast series. Discussion topics will include when to add an anti-obesity medication (AOM) to treat obesity, establishing the efficacy and safety of an AOM, sustaining weight loss, as well as dosing and administration information.
All content for The 411 on Obesity is the property of Novo Nordisk and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join Dr. Donna Ryan, Professor Emeritus at Pennington Biomedical Research Center at Baton
Rouge in Louisiana, alongside leading experts in the field of obesity and weight management, as they dive into challenges and strategies for the treatment of obesity in this podcast series. Discussion topics will include when to add an anti-obesity medication (AOM) to treat obesity, establishing the efficacy and safety of an AOM, sustaining weight loss, as well as dosing and administration information.
Experts Answer Your Top Questions About a GLP-1 RA Obesity Treatment
The 411 on Obesity
44 minutes 18 seconds
4 months ago
Experts Answer Your Top Questions About a GLP-1 RA Obesity Treatment
Join panelists Donna Ryan, MD, Ethan Lazarus, MD, and Lawrence Herman, DMSc PA-C, as they address frequently asked questions about the use of glucagon- like peptide-1 receptor agonist (GLP-1 RA) in appropriate adults with obesity or overweight and at least one weight-related comorbidity.
The 411 on Obesity
Join Dr. Donna Ryan, Professor Emeritus at Pennington Biomedical Research Center at Baton
Rouge in Louisiana, alongside leading experts in the field of obesity and weight management, as they dive into challenges and strategies for the treatment of obesity in this podcast series. Discussion topics will include when to add an anti-obesity medication (AOM) to treat obesity, establishing the efficacy and safety of an AOM, sustaining weight loss, as well as dosing and administration information.
